FDA Clearance Tracker · P130017-S057
COLOGUARD
Last checked: Nov 20, 2026Latest source record: Jul 20, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jul 20, 2024
Approved
Time to decision
176 days
Received Jan 26, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P130017-S057
- Device name
- COLOGUARD
- Applicant
- Exact Sciences Corporation
- Applicant location
- Medison, WI
- Received
- Jan 26, 2024
- Decided
- Jul 20, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P130017
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval for updating Cologuard labeling to include the completed Post-Approval study information.
Source documents
Other decisions for Exact Sciences Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P230043 · Decided Oct 3, 2024 · 286 days after receipt
Device type: System, colorectal neoplasia, DNA methylation and hemoglobin detection (PHP) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.